Pharmacytimes http://www.pharmacytimes.com/rss PharmacyTimes.com offers continuing education (CE) courses, career guidance for pharmacy students, online-only articles, digital versions of the print issue, and more, that are essential to pharmacists en-us Mon, 21 May 18 09:12:26 +0000 Mon, 21 May 18 09:12:26 +0000 FDA Approves Preventive Migraine Treatment http://www.pharmacytimes.com/news/fda-approves-preventive-migraine-treatment http://www.pharmacytimes.com/news/fda-approves-preventive-migraine-treatment Erenumab-aooe (Aimovig, Amgen) is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of the molecule that is involved in migraine attacks. Thu, 17 May 18 22:00:00 +0000 FDA Approves First Non-opioid Treatment for Management of Opioid Withdrawal Symptoms in Adults http://www.pharmacytimes.com/news/fda-approves-first-nonopioid-treatment-for-management-of-opioid-withdrawal-symptoms-in-adults http://www.pharmacytimes.com/news/fda-approves-first-nonopioid-treatment-for-management-of-opioid-withdrawal-symptoms-in-adults The FDA has approved lofexidine hydrochloride (Lucemyra) for the mitigation of opioid withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults. Wed, 16 May 18 21:57:00 +0000 Rapid Rabies Test Could Help Shorten Treatment http://www.pharmacytimes.com/news/rapid-rabies-test-could-help-shorten-treatment http://www.pharmacytimes.com/news/rapid-rabies-test-could-help-shorten-treatment A new rabies test developed at the CDC could mean people exposed to potentially rabid animals would forego the weeks-long regimen of shots to prevent the deadly disease. Wed, 16 May 18 19:00:00 +0000 FDA Approves First Epoetin Alfa Biosimilar for Anemia Treatment http://www.pharmacytimes.com/news/fda-approves-first-epoetin-alfa-biosimilar-for-anemia-treatment http://www.pharmacytimes.com/news/fda-approves-first-epoetin-alfa-biosimilar-for-anemia-treatment The FDA today approved epoetin alfa-epbx (Retacrit) as a biosimilar to epoetin alfa (Epogen/Procrit) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection Tue, 15 May 18 21:10:00 +0000 Multiple Sclerosis Therapy for Pediatric Patients Approved by FDA http://www.pharmacytimes.com/news/multiple-sclerosis-therapy-for-pediatric-patients-approved-by-fda http://www.pharmacytimes.com/news/multiple-sclerosis-therapy-for-pediatric-patients-approved-by-fda Officials with the FDA have approved fingolimod (Gilenya, Novartis) for the treatment of relapsing multiple sclerosis in pediatric patients aged 10 years and older, making it the first FDA-approved drug to treat MS in this population. Sat, 12 May 18 14:00:00 +0000 President Trump Urges More Competition to Lower Drug Costs http://www.pharmacytimes.com/news/president-trump-urges-more-competition-to-lower-drug-costs http://www.pharmacytimes.com/news/president-trump-urges-more-competition-to-lower-drug-costs The President also noted he has directed officials to take actions to end what he termed &quot;global freeloading,&quot; which he explained as lowered prices on drugs in other countries compared with the United States, where much of the investment funds for medical research originate. Fri, 11 May 18 21:12:00 +0000 Pharmacy Times Named Industry News Provider of the Year by American Pharmacy Purchasing Alliance http://www.pharmacytimes.com/news/pharmacy-times-named-industry-news-provider-of-the-year-by-american-pharmacy-purchasing-alliance http://www.pharmacytimes.com/news/pharmacy-times-named-industry-news-provider-of-the-year-by-american-pharmacy-purchasing-alliance Winners in the 12 categories include manufacturers, wholesalers, entrepreneurs, CEOs and pharmacy schools. Fri, 11 May 18 16:11:00 +0000 FDA Approves Drug Combination for Treating BRAF-positive Anaplastic Thyroid Cancer http://www.pharmacytimes.com/news/fda-approves-drug-combination-for-treating-brafpositive-anaplastic-thyroid-cancer http://www.pharmacytimes.com/news/fda-approves-drug-combination-for-treating-brafpositive-anaplastic-thyroid-cancer The FDA has approved Novartis&rsquo; combination treatment dabrafenib (Tafinlar) and trametinib (Mekinist) for the treatment of BRAF V600 mutation-positive anaplastic thyroid cancer (ATC) that cannot be removed by surgery or is metastatic. Mon, 07 May 18 14:50:00 +0000 Procter & Gamble Looks Ahead to Merck KGaA Acquisition http://www.pharmacytimes.com/news/procter--gamble-looks-ahead-to-merck-kgaa-acquisition http://www.pharmacytimes.com/news/procter--gamble-looks-ahead-to-merck-kgaa-acquisition Procter &amp; Gamble (P&amp;G) announced last month that it has agreed to acquire Merck KGaA&rsquo;s consumer health unit for 3.4 billion euros or about $4.2 billion. Thu, 03 May 18 16:00:00 +0000 Hormonal Contraceptive Prescribing By Pharmacists: A Brief Overview http://www.pharmacytimes.com/news/hormonal-contraceptive-prescribing-by-pharmacists-a-brief-overview http://www.pharmacytimes.com/news/hormonal-contraceptive-prescribing-by-pharmacists-a-brief-overview Pharmacists in all practice settings have opportunities to assist patients who use or seek to use contraception. Tue, 01 May 18 13:00:00 +0000 Identifying Gluten-Free Medications to Help Patients with Celiac Disease http://www.pharmacytimes.com/news/identifying-glutenfree-medications-to-help-patients-with-celiac-disease http://www.pharmacytimes.com/news/identifying-glutenfree-medications-to-help-patients-with-celiac-disease Pharmacists can help identify pharmaceuticals that could trigger symptoms in those with the autoimmune condition. Tue, 01 May 18 12:00:00 +0000 Drug Demonstrates Efficacy in Patients with Episodic Migraines http://www.pharmacytimes.com/news/drug-demonstrates-efficacy-in-patients-with-episodic-migraines http://www.pharmacytimes.com/news/drug-demonstrates-efficacy-in-patients-with-episodic-migraines Amgen&rsquo;s erenumab (Aimovig) achieved positive results in the first-of-its-kind phase 3b LIBERTY trial for the treatment of patients with episodic migraines who had previously failed 2 to 4 preventive treatments. Wed, 25 Apr 18 17:00:00 +0000 FDA OKs Burosumab for Rare Form of Rickets http://www.pharmacytimes.com/news/fda-oks-burosumab-for-rare-form-of-rickets http://www.pharmacytimes.com/news/fda-oks-burosumab-for-rare-form-of-rickets The serious condition leaves children with bowed legs, short stature, and bone and dental pain. Wed, 18 Apr 18 18:48:00 +0000 ASCP: Helping Seniors Manage Their Medications http://www.pharmacytimes.com/news/ascp-helping-seniors-manage-their-medications http://www.pharmacytimes.com/news/ascp-helping-seniors-manage-their-medications ASCP officials are urging pharmacists to join their membership, and become listed in the directory.&nbsp; Wed, 18 Apr 18 11:54:00 +0000 How Fiber Helps Prevent Colon Cancer http://www.pharmacytimes.com/news/how-fiber-helps-prevent-colon-cancer http://www.pharmacytimes.com/news/how-fiber-helps-prevent-colon-cancer It is important that pharmacists know the real deal about this mainstay of a healthy diet. Sun, 15 Apr 18 12:00:00 +0000 Nashville Directions in Pharmacy Meeting to Feature Insulin Product Theater http://www.pharmacytimes.com/news/nashville-directions-in-pharmacy-meeting-to-feature-insulin-product-theater http://www.pharmacytimes.com/news/nashville-directions-in-pharmacy-meeting-to-feature-insulin-product-theater For its upcoming Directions in Pharmacy<sup>&reg;</sup> conference in Nashville, Tennessee, <em>Pharmacy Times </em>Continuing Education<sup>TM</sup> is partnering with Lilly USA, LLC to present &ldquo;An Insulin Monotherapy Option for Patients on High Doses of Insulin.&rdquo; Fri, 13 Apr 18 15:50:00 +0000 Synthetic Cannabinoids Linked to Deaths in Illinois http://www.pharmacytimes.com/news/synthetic-cannabinoids-linked-to-deaths-in-illinois http://www.pharmacytimes.com/news/synthetic-cannabinoids-linked-to-deaths-in-illinois Three deaths are among 107 reported incidences of individuals who experienced severe bleeding after using synthetic cannabinoids. Tue, 10 Apr 18 15:22:00 +0000 Multimed Packaging Impact on Medication Adherence and Clinical Outcomes http://www.pharmacytimes.com/news/multimed-packaging-impact-on-medication-adherence-and-clinical-outcomes- http://www.pharmacytimes.com/news/multimed-packaging-impact-on-medication-adherence-and-clinical-outcomes- Forgetting to take a medication is the most frequently patient-reported reason for nonadherence. Sun, 08 Apr 18 20:41:00 +0000 Spring Blooms with the First Directions in Pharmacy Spring 2018 CE Series http://www.pharmacytimes.com/news/spring-blooms-with-the-first-directions-in-pharmacy-spring-2018-ce-series http://www.pharmacytimes.com/news/spring-blooms-with-the-first-directions-in-pharmacy-spring-2018-ce-series <em>Pharmacy Times</em> Continuing Education is hosting the 8th annual Directions in Pharmacy Spring Continuing Education Conference on April 14, at the Renaissance Nashville Hotel in Nashville, Tennessee. Fri, 06 Apr 18 22:11:00 +0000 A Rotation Abroad: Rural Pharmacy Practice in Southern Ecuador http://www.pharmacytimes.com/news/a-rotation-abroad-rural-pharmacy-practice-in-southern-ecuador http://www.pharmacytimes.com/news/a-rotation-abroad-rural-pharmacy-practice-in-southern-ecuador What sets my time in Ecuador apart from any other rotation that I&rsquo;ve done or will do is that every element of growth, and every challenge is presented simultaneously. Wed, 04 Apr 18 14:00:00 +0000 Health Agencies Warn Against Synthetic Cannabinoids http://www.pharmacytimes.com/news/health-agencies-warn-against-synthetic-cannabinoids http://www.pharmacytimes.com/news/health-agencies-warn-against-synthetic-cannabinoids Multiple incidences of severe bleeding prompted has prompted the Illinois Department of Public Health (IDPH) to issue a warning this week about the dangers of synthetic cannabinoids. Fri, 30 Mar 18 21:00:00 +0000 Pharmacist Feature Friday: A Pharmacist is a PharmASSIST http://www.pharmacytimes.com/news/pharmacist-feature-friday-a-pharmacist-is-a-pharmassist http://www.pharmacytimes.com/news/pharmacist-feature-friday-a-pharmacist-is-a-pharmassist Pharmacists play a vital role in the continuum of patient care.<br /> &nbsp; Fri, 30 Mar 18 15:25:00 +0000 FDA Expands Indication of ALL Treatment for Patients with Increased Relapse Risk http://www.pharmacytimes.com/product-news/fda-expands-indication-of-all-treatment-for-patients-with-increased-relapse-risk http://www.pharmacytimes.com/product-news/fda-expands-indication-of-all-treatment-for-patients-with-increased-relapse-risk Officials with the FDA have expanded the approval of Amgen&#39;s blinatumomab (Blincyto) to include the treatment of adults and children with B-cell precursor acute lymphoblastic leukemia who are in remission but still have minimal residual disease. Fri, 30 Mar 18 13:00:00 +0000 Your Business, Only Better http://www.pharmacytimes.com/news/your-business-only-better http://www.pharmacytimes.com/news/your-business-only-better The Power of the Benzer Pharmacy Franchisee Program.<br /> &nbsp; Wed, 28 Mar 18 11:00:00 +0000 Some in Health Care Industry Applaud Trump's Decision to Sign Spending Bill http://www.pharmacytimes.com/news/some-in-health-care-industry-applaud-trumps-decision-to-sign-spending-bill http://www.pharmacytimes.com/news/some-in-health-care-industry-applaud-trumps-decision-to-sign-spending-bill The $1.3 billion package includes increased funding for agencies such as the Department of Health and Human Services and the Centers for Medicare &amp; Medicaid Services,&nbsp;<br /> &nbsp; Fri, 23 Mar 18 20:06:00 +0000